Perioperative considerations With their superiority in glycaemic control, low incidence of fasting hypoglycaemia, roles in weight management, and established evidence for their cardiovascular benefits, GLP-1 agonists present as highly attractive agents in improving patient outcomes in the perioperative setting, with growing interest for these agents to be continued without perioperative interruption
References Willard FS, Douros JD, Gabe MB, et al
Understanding who benefits most helps you make an informed decision with your provider
TABLE 3 Summary of methods used to identify GLP-2R expression throughout the gastrointestinal tract
However, once ROS levels exceed the buffering capacity on response to multiple stimuli, a series of adaptive responses that are combined with inflammatory responses followed by intracellular damage are activated, which further lead to progressive mitochondrial dysfunction and cell death [25]
However, these reports do not prove that Wegovy caused these events